Why do People With Low Back Pain Fear and Avoid Lifting?

NCT ID: NCT05192187

Last Updated: 2022-02-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

325 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-28

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators' main focus of this trial will be to investigate

* why people with low back pain perceive lifting (with a bent back) as harmful.
* whether general measures of pain-related fear are associated with task-specific measures of perceived harmfulness
* why people with low back pain avoid lifting (with a bent back) This will be investigated using self-report (i.e., questionnaires)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Back Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LBP

This group will be asked to complete self-reported questionnaires on a single occasion (cross-sectional)

Group Type EXPERIMENTAL

Cross-sectional self-report (questionnaires)

Intervention Type OTHER

participants in this group will be ask to complete questionnaires on one occasion (i.e., cross-sectional investigation). The questionnaires will consist of a self-developed questionnaire and standard questionnaires. The main aspects of the self-developed questionnaires are

* perceived harmfulness of activities (selection of PHODA-SeV)
* cognitions about lifting and pain
* reasons for avoidance behaviour (lifting)

Standardised questionnaires include

* NRS for pain
* TSK-11
* FABQ
* RMDQ

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cross-sectional self-report (questionnaires)

participants in this group will be ask to complete questionnaires on one occasion (i.e., cross-sectional investigation). The questionnaires will consist of a self-developed questionnaire and standard questionnaires. The main aspects of the self-developed questionnaires are

* perceived harmfulness of activities (selection of PHODA-SeV)
* cognitions about lifting and pain
* reasons for avoidance behaviour (lifting)

Standardised questionnaires include

* NRS for pain
* TSK-11
* FABQ
* RMDQ

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* low back pain \>3 months

Exclusion Criteria

* healthy persons
* low back pain \<3 months
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hasselt University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Thomas Matheve

Postdoctoral researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Matheve, PhD

Role: PRINCIPAL_INVESTIGATOR

Hasselt University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hasselt University

Hasselt, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Thomas Matheve, PhD

Role: CONTACT

32(0)11 28 69 39

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Thomas Matheve, PhD

Role: primary

Lotte Janssens, PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ThomasMatheve-2021-3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Weight Reduction in CLBP
NCT04824248 RECRUITING NA